ALK and lung adenocarcinoma: Here, we reported a case with concomitant ALK rare double-fusion, namely PLEKHA7-ALK and INPP5D-ALK in a patient diagnosed with lung adenocarcinoma who showed favorable response to alectinib following chemotherapy failure.